HTA93 Mixture Cure Models: A New Paradigm to Model Long-Term Remission (LTR) for Chimeric Antigen Receptor (CAR) T-Cell Therapies?
Abstract
Authors
C Theriou D Meszarosova A Berardi
C Theriou D Meszarosova A Berardi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now